Osteoblast/Osteoclast Development and Function in Osteogenesis Imperfecta - Osteogenesis Imperfecta - page 49

[129] Gebken J, Brenner R, Feydt A, Notbohm H, Brinckmann J,

Muller PK, et al. Increased cell surface expression of receptors
for transforming growth factor-beta on osteoblasts from patients
with Osteogenesis imperfecta. Pathobiol 2000;68(3):106-12.

[146] Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L,

Bergwitz C, et al. Cellular mechanism of decreased bone in Brtl
mouse model of OI: imbalance of decreased osteoblast function
and increased osteoclasts and their precursors. J Bone Miner Res
2008;23(12):1983-94. [130] Morike M, Schulz M, Brenner RE, Bushart GB, Teller WM,

Vetter U. In vitro expression of osteoblastic markers in cells iso-
lated from normal fetal and postnatal human bone and from
bone of patients with osteogenesis imperfecta. J Cell Physiol
1993;157(3):439-44.

[147] Zhang H, Doty SB, Hughes C, Dempster D, Camacho NP.

Increased resorptive activity and accompanying morpho-
logical alterations in osteoclasts derived from the oim/oim
mouse model of osteogenesis imperfecta. J Cell Biochem
2007;102(4):1011-20. [131] Fedarko NS, Vetter UK, Weinstein S, Robey PG. Age-related

changes in hyaluronan, proteoglycan, collagen, and osteonectin
synthesis by human bone cells. J Cell Physiol 1992;151(2):215-27.

[148] Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM,

Wight TN, Helene Sage E. SPARC-null mice display abnor-
malities in the dermis characterized by decreased collagen
ibril diameter and reduced tensile strength. J Invest Dermatol
2003;120(6):949-55.

[132] Fedarko NS, D'Avis P, Frazier CR, Burrill MJ, Fergusson V,

Tayback M, et al. Cell proliferation of human ibroblasts and
osteoblasts in osteogenesis imperfecta: inluence of age. J Bone
Miner Res 1995;10(11):1705-12. [149] Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT,

et al. Mice that lack thrombospondin 2 display connective tis-
sue abnormalities that are associated with disordered collagen
ibrillogenesis, an increased vascular density, and a bleeding
diathesis. J Cell Biol 1998;140(2):419-30.

[133] Fedarko NS, Sponseller PD, Shapiro JR. Long-term extracellu-

lar matrix metabolism by cultured human osteogenesis imper-
fecta osteoblasts. J Bone Miner Res 1996;11(6):800-5.

[134] Fedarko NS, Robey PG, Vetter UK. Extracellular matrix stoichi-

ometry in osteoblasts from patients with osteogenesis imper-
fecta. J Bone Miner Res 1995;10(7):1122-9.

[150] Chen XD, Shi S, Xu T, Robey PG, Young MF. Age-related osteo-

porosis in biglycan-deicient mice is related to defects in bone
marrow stromal cells. J Bone Miner Res 2002;17(2):331-40. [135] Fedarko NS, Vetter U, Robey PG. The bone cell biology of

osteogenesis imperfecta. Connect Tissue Res 1995;31(4):269-73. [151] Danielson KG, Baribault H, Holmes DF, Graham H, Kadler

KE, Iozzo RV. Targeted disruption of decorin leads to abnor-
mal collagen ibril morphology and skin fragility. J Cell Biol
1997;136(3):729-43.

[136] Fedarko NS, Vetter UK, Robey PG. Age-related changes in

bone matrix structure in vitro. Calcif Tissue Int 1995;56(Suppl.
1):S41-3.

[137] Wells T, Davidson C, Morgelin M, Bird JL, Bayliss MT, Dudhia J.

Age-related changes in the composition, the molecular stoichi-
ometry and the stability of proteoglycan aggregates extracted
from human articular cartilage. Biochem J 2003;370(Pt 1):69-79.

[152] Ameye L, Young MF. Mice deicient in small leucine-rich pro-

teoglycans: novel in vivo models for osteoporosis, osteoarthri-
tis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal
diseases. Glycobiology 2002;12(9):107R-116RR.

[138] Sweet MB, Thonar EJ, Marsh J. Age-related changes in proteo-

glycan structure. Arch Biochem Biophys 1979;198(2):439-48.

[153] Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD,

Franceschi RT. Bone morphogenetic proteins, extracellular
matrix, and mitogen-activated protein kinase signaling pathways
are required for osteoblast-speciic gene expression and differen-
tiation in MC3T3-E1 cells. J Bone Miner Res 2002;17(1):101-10.

[139] Grzesik WJ, Frazier CR, Shapiro JR, Sponseller PD, Robey PG,

Fedarko NS. Age-related changes in human bone proteogly-
can structure. Impact of osteogenesis imperfecta. J Biol Chem
2002;277(46):43638-47. [154] Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. Fibroblast

growth factor 2 induction of the osteocalcin gene requires
MAPK activity and phosphorylation of the osteoblast transcrip-
tion factor, Cbfa1/Runx2. J Biol Chem 2002;277(39):36181-87.

[140] Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH,

Lichtler AC, et al. Use of type I collagen green luorescent protein
transgenes to identify subpopulations of cells at different stages
of the osteoblast lineage. J Bone Miner Res 2002;17(1):15-25. [155] Xiao G, Jiang D, Thomas P, Benson MD, Guan K,

Karsenty G, et al. MAPK pathways activate and phosphorylate
the osteoblast-speciic transcription factor, Cbfa1. J Biol Chem
2000;275(6):4453-9.

[141] Kalajzic I, Staal A, Yang WP, Wu Y, Johnson SE, Feyen JH, et al.

Expression proile of osteoblast lineage at deined stages of dif-
ferentiation. J Biol Chem 2005;280(26):24618-26.

[142] Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I,

Kalinovsky J, et al. Immature osteoblast lineage cells increase
osteoclastogenesis in osteogenesis imperfecta murine. Am J
Pathol 2010;176(5):2405-13.

[156] Chessler SD, Byers PH. Defective folding and stable association

with protein disulide isomerase/prolyl hydroxylase of type I
procollagen with a deletion in the pro alpha 2(I) chain that pre-
serves the Gly-X-Y repeat pattern. J Biol Chem 1992;267(11):
7751-7. [143] Gioia R, Panaroni C, Besio R, Palladini G, Merlini G, Giansanti V,

et al. Impaired osteoblastogenesis in a murine model of dominant
osteogenesis imperfecta: a new target for osteogenesis imperfecta
pharmacological therapy. Stem Cells 2012;30(7):1465-76.

[157] Chessler SD, Byers PH. BiP binds type I procollagen pro alpha

chains with mutations in the carboxyl-terminal propeptide
synthesized by cells from patients with osteogenesis imper-
fecta. J Biol Chem 1993;268(24):18226-33. [144] Rauch F, Travers R, Paritt AM, Glorieux FH. Static and

dynamic bone histomorphometry in children with osteogen-
esis imperfecta. Bone 2000;26(6):581-9.

[158] Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GK, Abe K,

et al. ER stress-mediated apoptosis in a new mouse model of
osteogenesis imperfecta. PLoS Genet 2008;4(2):e7. [145] Kalajzic I, Terzic J, Rumboldt Z, Mack K, Naprta A,

Ledgard F, et al. Osteoblastic response to the defective
matrix in the osteogenesis imperfecta murine (oim) mouse.
Endocrinology 2002;143(5):1594-601.